New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments
In this podcast episode, listen to myeloma experts Natalie S. Callander, MD, and Shaji Kumar, MD, respond to audience questions from a live CCO Webinar discussing current guidelines and treatment advances for patients with relapsed/refractory multiple myeloma.
Decera Clinical Education Oncology Podcast · Natalie S. Callander MD, Shaji Kumar MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Natalie S. Callander, MD, and Shaji Kumar, MD, answer audience questions from a live CCO Webinar on relapsed/refractory myeloma regarding challenges in treating patients in this setting, including optimizing treatment choices and sequencing of treatments, MRD testing in myeloma, promising BCMA-targeted agents, the promise and value of CAR T-cell therapy in myeloma, and more.
Presenters:
Natalie S. Callander, MD
Professor of Medicine
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin
Shaji Kumar, MD
Department of Hematology
Mayo Clinic
Rochester, Minnesota
Content based on an online CME program supported by educational grants from GlaxoSmithKline LLC and Sanofi Genzyme.
Link to full program, including associated downloadable slidesets:
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.